V. Barak

911 total citations
28 papers, 774 citations indexed

About

V. Barak is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, V. Barak has authored 28 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in V. Barak's work include Glycosylation and Glycoproteins Research (3 papers), Immune Cell Function and Interaction (3 papers) and Immune Response and Inflammation (3 papers). V. Barak is often cited by papers focused on Glycosylation and Glycoproteins Research (3 papers), Immune Cell Function and Interaction (3 papers) and Immune Response and Inflammation (3 papers). V. Barak collaborates with scholars based in Israel, United States and France. V. Barak's co-authors include Benjamin Nisman, Yoram Abramov, Joseph G. Schenker, I. Kalickman, Aya Abrahamov, S Yatziv, Ari Zimran, Sozos J. Fasouliotis, S.O. Anteby and David Hasdai and has published in prestigious journals such as Blood, American Journal of Obstetrics and Gynecology and Medicine & Science in Sports & Exercise.

In The Last Decade

V. Barak

28 papers receiving 738 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
V. Barak 218 206 204 163 132 28 774
Jerome F. Strauss 168 0.8× 239 1.2× 115 0.6× 36 0.2× 153 1.2× 16 909
J.Y. Kim 290 1.3× 152 0.7× 86 0.4× 32 0.2× 55 0.4× 40 682
G Hamilton 233 1.1× 234 1.1× 73 0.4× 40 0.2× 51 0.4× 28 850
G Korczak-Kowalska 397 1.8× 96 0.5× 269 1.3× 26 0.2× 63 0.5× 62 764
Gavin Pickett 111 0.5× 297 1.4× 35 0.2× 99 0.6× 44 0.3× 18 648
J Koudstaal 125 0.6× 214 1.0× 36 0.2× 68 0.4× 159 1.2× 28 855
Elisa Schmoeckel 392 1.8× 401 1.9× 202 1.0× 22 0.1× 166 1.3× 92 1.2k
Mark D. Walsh 180 0.8× 148 0.7× 106 0.5× 40 0.2× 33 0.3× 13 547
Xiaohong Yu 153 0.7× 147 0.7× 58 0.3× 30 0.2× 106 0.8× 32 540
Siew Meng Chong 149 0.7× 171 0.8× 33 0.2× 119 0.7× 67 0.5× 22 649

Countries citing papers authored by V. Barak

Since Specialization
Citations

This map shows the geographic impact of V. Barak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Barak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Barak more than expected).

Fields of papers citing papers by V. Barak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Barak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Barak. The network helps show where V. Barak may publish in the future.

Co-authorship network of co-authors of V. Barak

This figure shows the co-authorship network connecting the top 25 collaborators of V. Barak. A scholar is included among the top collaborators of V. Barak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Barak. V. Barak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leibowitz, David, et al.. (2004). TUMOR NECROSIS FACTOR AND INTERLEUKIN-6 LEVELS IN HYPERTENSIVE PATIENTS WITH AND WITHOUT LEFT VENTRICULAR HYPERTROPHY. Journal of Hypertension. 22(Suppl. 1). S156–S156. 1 indexed citations
2.
Abramov, Yoram, S.O. Anteby, Sozos J. Fasouliotis, & V. Barak. (2001). Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. American Journal of Obstetrics and Gynecology. 184(3). 354–355. 50 indexed citations
3.
Nisman, Benjamin, G Amir, Joel Lafair, et al.. (2000). Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.. PubMed. 19(4C). 3549–52. 40 indexed citations
4.
Geva, Eli, Ami Amit, Joseph B. Lessing, et al.. (1999). Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?. PubMed. 44(2). 91–6. 21 indexed citations
5.
Tomer, Yaron, V. Barak, Boris Gilburd, & Yehuda Shoenfeld. (1999). Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type response.. PubMed. 17(5). 521–6. 12 indexed citations
6.
Barak, V., Benjamin Nisman, I. Kalickman, et al.. (1999). Cytokines in Gaucher's disease.. PubMed. 10(2). 205–10. 154 indexed citations
7.
Nisman, Benjamin, V. Barak, Norman Heching, et al.. (1998). Cytokeratin Markers in Malignant Pleural Mesothelioma. Cancer Detection and Prevention. 22(5). 416–421. 9 indexed citations
8.
Abramov, Yoram, V. Barak, Benjamin Nisman, & Joseph G. Schenker. (1997). Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertility and Sterility. 67(2). 261–265. 150 indexed citations
9.
Shapira, Lior, Aubrey Soskolne, Amal Halabi, V. Barak, & Adam Stabholz. (1997). Induction of tumor necrosis factor α and interleukin-1β in subcutaneously implanted chamber by lipopolysaccharide. Journal of Endotoxin Research. 4(5). 325–329. 3 indexed citations
10.
Levi, Shlomit, J Barkans, T. M. Newman, et al.. (1996). IDENTIFICATION OF INTER-LEUKIN-2 IN HUMAN PERIPHERAL BLOOD EOSINOPHILS. 87. 155–161. 2 indexed citations
11.
Hasdai, David, et al.. (1996). Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.. Heart. 76(1). 24–28. 75 indexed citations
12.
Leibovici, Vera, et al.. (1995). Imbalance of immune responses in patients with chronic and widespread fungal skin infection. Clinical and Experimental Dermatology. 20(5). 390–394. 21 indexed citations
13.
Nisman, Benjamin, et al.. (1995). 1259 CYFRA 21-1 and TPS—new markers in lung cancer. European Journal of Cancer. 31. S263–S263. 6 indexed citations
14.
Shimonovitz, Shlomo, et al.. (1994). High concentration of soluble interleukin-2 receptors in ejaculate with low sperm motility. Human Reproduction. 9(4). 653–655. 20 indexed citations
15.
Barak, V., et al.. (1993). In vivo anti-inflammatory effects of the M20 IL-1 Inhibitor: II. Effects on serum reactants. Biotherapy. 6(4). 271–277. 5 indexed citations
16.
Peritt, David, et al.. (1992). The M20 IL-1 inhibitor. Journal of Immunological Methods. 155(2). 167–174. 11 indexed citations
18.
Peritt, David, et al.. (1992). The M20 IL-1 inhibitor. Journal of Immunological Methods. 155(2). 159–165. 9 indexed citations
19.
Friedman, G., V. Barak, Tova Chajek‐Shaul, et al.. (1991). Recombinant human interleukin-1 suppresses lipoprotein lipase activity, but not expression of lipoprotein lipase mRNA in mesenchymal rat heart cell cultures. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1089(1). 83–87. 11 indexed citations
20.
Barak, V., et al.. (1989). Solitary nonparasitic cyst of the liver: a rare cause of abdominal distension.. PubMed. 84(9). 1095–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026